Pitavastatin (Calcium) - HY-B0144
Nur noch %1 verfügbar
Catalog #
HY-B0144
Ab
43,00 €
Pitavastatin Calcium (NK-104 hemicalcium) is a potent hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor. Pitavastatin Calcium (NK-104 hemicalcium) inhibits cholesterol synthesis from acetic acid with an IC50 of 5.8 nM in HepG2 cells. Pitavastatin Calcium is an efficient hepatocyte low-density lipoprotein-cholesterol (LDL-C) receptor inducer. Pitavastatin Calcium also possesses anti-atherosclerotic, anti-asthmatic, anti-osteoarthritis, antineoplastic, neuroprotective, hepatoprotective and reno-protective effects[1][2][3][8].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-B0144/Pitavastatin-Calcium-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| Alternative Names | NK-104 (hemicalcium); Pitavastatin (hemicalcium) |
| CAS | 147526-32-7 |
| Storage | 4°C (Powder, sealed storage, away from moisture and light) |
| MWT | 440.49 |
| Solubility | DMSO : ≥ 50 mg/mL |
| Clinical Information | Launched |
| Target | Apoptosis;Autophagy;HMG-CoA Reductase (HMGCR);Mitophagy |
| Application: | Cancer-programmed cell death |
|---|